RPG Life Sciences Limited — Earnings Release 2023

Aug 2, 2022

==> picture [159 x 62] intentionally omitted <==

Q1 FY23 Revenue from operations grew by 19 % Y-o-Y and 24% Q-o-Q. PBT grew by 30% Y-o-Y and 130% Q-o-Q.

Mumbai, 02 August, 2022 : RPG Life Sciences Limited has announced its financial results for the quarter ended June 30, 2022.

				Y-o-Y Revenue from operationsY-o-Y PBT
Q1	FY23	Highlights	Rs	128.93 crores – up from Rs 108.13 crores Rs 25.12 crores – up from Rs 19.27 crores

RPG Life Sciences, engaged in the manufacturing and marketing of pharmaceutical products, posted a jump in PBT by 30% Y-o-Y and by 130% Q-o-Q for Q1 FY23. Revenue from operations at Rs 128.93 crores registered a growth of 19% Y-o-Y and a growth of 24% Q-o-Q for Q1 FY23. The Company maintained the upward trajectory in EBITDA margin, which improved from 21.6% to 22.5% Y-o-Y.

Mr. Yugal Sikri, Managing Director, RPG Life Sciences Ltd. said, “In Q1 FY23, the overall performance of the Company continued to be strong despite the geo-political challenges impacting supply chain and costs. Revenue and PBT grew by 19% and 30% respectively Y-o-Y. EBITDA margin retained its upward trajectory growing from 21.6% to 22.5% Y-o-Y.

Domestic Formulations business has recorded a robust growth both in value and volumes - significantly and consistently better than the market. While our comprehensive life cycle management program for legacy brands is helping them register healthy growth, our new product portfolio comprising of newer and progressive segments is also witnessing an impressive uptake. We have successfully forayed into a new therapy area - Rheumatology, which is strengthening our Specialty segment. Salesforce productivity continues to register healthy upward momentum. International Formulations business has shown a robust recovery while API business continue to register growth. Our unique digital initiative, RPGServ, is having impressive traction in physician connect and engagement. Going forward, we stay committed to implementing our Transformation Agenda to grow both topline and bottomline across segments.”

RPG Life Sciences Ltd (www.rpglifesciences.com):

RPG Life Sciences Ltd, part of RPG Enterprises, is an integrated pharmaceutical company operating in the domestic and international markets in the branded formulations, global generics and synthetic APIs space. The company is a research-based pharmaceutical company, producing a wide range of quality, affordable medicines. Its brands are highly trusted by healthcare professionals and patients.

RPG Enterprises (www.rpggroup.com):

RPG Enterprises, established in 1979, is one of India’s fastest growing business groups with a turnover of US$ 4 Billion. The group has diverse business interests in the areas of Infrastructure, Tyres, Pharma, IT and Specialty as well as in emerging innovation-led technology businesses.

Media Contact:

Sumeet Chatterjee Senior Vice President – Corporate Brand and Group Communications +91 9820340650 | sumeet@rpg.in

==> picture [62 x 63] intentionally omitted <==

==> picture [133 x 27] intentionally omitted <==